Detalles de la búsqueda
1.
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
Cancer Immunol Immunother
; 72(7): 1957-1969, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811662
2.
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
Cancer Immunol Immunother
; 71(7): 1633-1644, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750662
3.
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
J Cancer Res Clin Oncol
; 149(5): 1993-2008, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767193
4.
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.
Int Immunopharmacol
; 114: 109519, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459922
5.
Systemic therapy with or without locoregional therapy for advanced hepatocellular carcinoma: A systematic review and network meta-analysis.
Crit Rev Oncol Hematol
; 184: 103940, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805079
6.
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis.
Expert Rev Gastroenterol Hepatol
; 17(1): 73-83, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476076
7.
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis.
Clin Exp Med
; 23(6): 2115-2129, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385419
8.
A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response.
Front Pharmacol
; 14: 1101749, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36909185
9.
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis.
Clin Exp Metastasis
; 40(4): 255-287, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308706
10.
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Expert Rev Gastroenterol Hepatol
; 17(6): 623-633, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148261
11.
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis.
Immunotherapy
; 15(9): 669-678, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37140011
12.
The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Front Immunol
; 13: 827788, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211122
13.
The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Front Immunol
; 13: 872353, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35464489
14.
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis.
Immunotherapy
; 14(18): 1481-1496, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537255
Resultados
1 -
14
de 14
1
Próxima >
>>